Levosimendan-induced venodilation is mediated by opening of potassium channels.

导出 LinkOut

翻译打印收藏纠错

作者： Daniel,Burkhoff ^[1] ; Stuart,Rich ^[2] ; Piero,Pollesello ^[3] ; Zoltán,Papp ^[4]

作者单位： Cardiovascular Research Foundation, New York, NY, USA. ^[1] Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. ^[2] Critical Care, Orion Pharma, Espoo, Finland. ^[3] Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, 22 Móricz Zsigmond Str., Debrecen, H-4032, Hungary. ^[4] HAS-UD Vascular Biology and Myocardial Pathophysiology Research Group, Hungarian Academy of Sciences, Budapest, Hungary. ^[5]

关键词 Heart failure with preserved ejection fraction Levosimendan Pharmacology Pulmonary hypertension Therapy Venodilation

主题词人类(Humans);腙类(Hydrazones);钾通道(Potassium Channels);哒嗪类(Pyridazines);血管舒张药(Vasodilator Agents)

DOI 10.1002/ehf2.13669

PMID 34716759

发布时间 2022-03-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

ESC heart failure

2021年8卷6期

4454-4464页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Levosimendan-induced venodilation is mediated by opening of potassium channels.

ESC heart failure

相似文献

ESC heart failure

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Levosimendan-induced venodilation is mediated by opening of potassium channels.

ESC heart failure

相似文献

ESC heart failure

相关期刊

检索历史清除